RECENT POSTS
MAD MONEY FEATURES
PODCASTSWatch the Lightning Round whenever and wherever you want.
OFFICIAL MAD MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
CRAMER'S SOUNDBOARDAdmit it: You’ve always wanted to hit the “They know nothing!” button. Here’s your chance.
CRAMER QUICK PICSCheck out the Mad Money host on set, back to school, behind the scenes and more.
VIDEOSGet all your favorite Cramer clips right here.
SHOP FOR MAD MERCHANDISEBuy Cramer books, bobbleheads and other Mad Money merchandise.
RING TONESPick up the phone! It’s Cramer! New Mad Money sounds for your cell phone.
TEXT MESSAGE ALERTMad Money’s mobile. Get show highlights sent to your phone.
Text Size 
 |
] should consider selling, as you did, in light of unrelenting coverage of Vytorin issues by the press. Since Vytorin is a joint venture with Merck [MRK
Loading...
()
], do you recommend selling MRK as well? --HannahCramer says: “I think the stock’s anticipating that the drug will actually be pulled from the market. It’s not as big a percentage of the earnings as it is for Schering.”
___
Jim: Should I be worried about all of the insider selling at International Business Machines [IBM
Loading...
()
] and sell my stock now? IBM still seems to have good growth potential for the next 12 months. --Todd
Cramer says: “I agree with you, Todd. This stock has come down just dramatically along with the rest of the tech. I think it’s overdone…I think IBM’s an opportunity.”
___
Jim: When you were at Penn State you recommended CPFL Energia [CPL
Loading...
()
]…CPL recently released earnings that were solid but down from the previous year and the stock has been plummeting…My research tells me that the dividend allows us to be patient. However, I could be missing something here and your opinion on this would be really appreciated. Thanks for the investment ideas you generate on your show and the education you provide. --Denny
Cramer says: “Get a 7% yield in an emerging country that is much more stable fiscally and financially than we are, I say you pull the trigger.”
___
Cramer: Vertex Pharmaceuticals [VRTX
Loading...
()
], the maker of Telaprevir, was one of your recommendations during Biotech Week. It was downgraded today by an Oppenheimer analyst…Does the downgrade provide enough influence to switch out of Vertex for something like Celgene [CELG
Loading...
()
]? --Pat
Cramer says: “I think it’s a mistake…to sell Vertex. I think it’s terrific to buy Celgene.”
___
Hi Cramer!: Signs say to buy Norfolk Southern [NSC
Loading...
()
]…How do you like Norfolk, even though CSX [CSX
Loading...
()
] has the market? What is the main long- term objective that is driving growth? --Lisa in Illinois
Cramer says: “I have to be careful. I think a lot of the hedge funds are in these rails. They scare me, these hedge funds. A lot of them are under liquidation. I prefer CSX to Norfolk Southern because I like [CEO] Mike Ward very much” but be careful of the rails.
Jim's charitable trust owns Celgene and National Oilwell Varco.
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes